The MHRA has told healthcare providers to stop using, quarantine and dispose of all NGPod handheld devices and sensors used to support nasogastric-tube placement.
The manufacturer has ceased trading in the UK and can no longer support the product. The regulator says that although the business closure is not itself a safety event, an earlier corrective action followed two UK incident reports, including one fatal outcome.
In those incidents, the device produced a green result suggesting acidic contact and correct tube placement, but the nasogastric tube was subsequently found in the lung. The MHRA advises providers to use alternative CE-marked pH-testing methods intended for human gastric aspirate.
Organisations should check stocks, maintain continuity of care and report suspected or actual device incidents through the appropriate UK reporting route. The notice is directed at healthcare professionals and does not instruct patients to take independent action.
